Wiktor Kuliczkowski
Overview
Explore the profile of Wiktor Kuliczkowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gil R, Gajewski P, Pawlowski T, Tajstra M, Kleczynski P, Szuldrzynski K, et al.
Kardiol Pol
. 2025 Mar;
83(2):256.
PMID: 40066970
No abstract available.
2.
Slawek-Szmyt S, Stepniewski J, Kurzyna M, Klaudel J, Kuliczkowski W, Lewandowski M, et al.
Respir Res
. 2025 Mar;
26(1):87.
PMID: 40045310
Background: Data on interventional treatment of intermediate-high (and high-risk pulmonary embolism (PE) are limited. The authors sought to evaluate the safety and efficacy of catheter-directed mechanical aspiration thrombectomy (CDMT) in...
3.
Blaziak M, Przybylski R, Wietrzyk W, Balcer B, Dolata N, Kuliczkowski W
Pol Arch Intern Med
. 2025 Feb;
PMID: 39931822
No abstract available.
4.
Voll F, Olivecronab G, Ferenc M, Hellig F, Schlundt C, Wohrle J, et al.
Cardiovasc Interv Ther
. 2025 Feb;
40(2):296-305.
PMID: 39918675
New-generation single-layer polytetrafluorethylene (PTFE-) or polyurethane (PU-) covered stent (CS) for the treatment of coronary artery perforation (CAP) during PCI offer high procedural efficacy. To evaluate the comparative long-term safety...
5.
Blaziak M, Jarocki M, Wietrzyk W, Modrzejewska K, Swierczek I, Kuliczkowski W
Postepy Kardiol Interwencyjnej
. 2025 Feb;
20(4):509-510.
PMID: 39897008
No abstract available.
6.
7.
Gil R, Gajewski P, Pawlowski T, Tajstra M, Kleczynski P, Szuldrzynski K, et al.
Kardiol Pol
. 2025 Jan;
82(12):1281-1283.
PMID: 39775559
No abstract available.
8.
Blaziak M, Jeruzalski T, Plawiak P, Granat J, Czerkies J, Kosiarska M, et al.
Kardiol Pol
. 2025 Jan;
83(2):194-196.
PMID: 39743912
No abstract available.
9.
Kubica J, Adamski P, Ostrowska M, Kubica A, Gajda R, Badariene J, et al.
Int J Cardiol
. 2024 Dec;
421():132897.
PMID: 39647786
De-escalation of dual antiplatelet (DAPT) intensity may be considered in patients with high risk of bleeding after acute coronary syndrome. Some high risk patients after de-escalation may require antithrombotic therapy...
10.
Blaziak M, Urban S, Jura M, Wietrzyk W, Stanczykiewicz B, Jarocki M, et al.
Kardiol Pol
. 2024 Oct;
82(12):1220-1229.
PMID: 39440741
Background: Randomized controlled trials (RCTs) comparing the clinical outcomes of fractional flow reserve (FFR)-guided and angiography-guided revascularization in patients with coronary artery disease yielded inconsistent results. Aims: This study aimed...